Frameless Stereotaxy in Stereoelectroencephalography Using Intraoperative Computed Tomography

Background: Pharmacoresistant epilepsy affects approximately one-third of all epilepsy patients, and resective surgery may offer favorable outcomes for carefully selected patients with focal epilepsy. The accurate identification of the epileptogenic zone (EZ) is essential for successful surgery, particularly in cases where non-invasive diagnostics are inconclusive. Invasive diagnostics with stereoelectroencephalography (SEEG) offer a reliable approach to localizing the EZ, especially in MRI-negative cases. Methods: This retrospective study analyzed the data of 22 patients with pharmacoresistant epilepsy who underwent frameless stereotactic SEEG electrode implantation with automated CT-based registration between September 2016 and November 2024. For measuring accuracy, Euclidean distance, radial deviation, angular deviation, and depth deviation were calculated for each electrode. Results: A total of 153 depth electrodes were implanted, targeting various cortical regions. The median Euclidean distance at the entry point was 1.54 mm (IQR 1.31), with a radial deviation of 1.33 mm (IQR 1.32). At the target level, the median Euclidean distance was 2.61 mm (IQR 1.53), with a radial deviation of 1.67 mm (IQR 1.54) and depth deviation of 0.95 mm (IQR 2.43). Accuracy was not significantly affected by electrode order, anatomical location, skull thickness, or intracranial length. Conclusions: These findings demonstrate that frameless stereotactic SEEG electrode implantation is safe and feasible for identifying the EZ. The integration of automatic intraoperative CT-based registration ensures precision. While maintaining workflow efficiency, it achieves accuracy comparable to frame-based methods. Further studies with larger cohorts are warranted to validate these results and assess their impact on surgical outcomes.